A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus-Reference-Cited by-同舟云学术

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Published:2016-11-21 Issue:1 Volume:34 Page:29-38
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Heise Tim,Hövelmann Ulrike,Zijlstra Eric,Stender-Petersen Kirstine,Jacobsen Jacob Bonde,Haahr Hanne

Funder

Novo Nordisk

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-016-0418-6.pdf

Reference28 articles.

1. Heller S, McCance DR, Moghissi E, Nazeri A, Kordonouri O. Diversity in diabetes: the role of insulin aspart. Diabetes Metab Res Rev. 2012;28:50–61.

2. US Food and Drug Administration. Inactive ingredient search for approved drug products. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm . Accessed 7 Oct 2016.

3. Heise T, Hövelmann U, Brøndsted L, Adrian CL, Nosek L, Haahr H. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart. Diabetes Obes Metab. 2015;17:682–8.

4. Heise T, Stender-Petersen K, Hövelmann U, et al. Pharmacokinetic and pharmacodynamic properties of faster-acting insulin aspart versus insulin aspart across a clinically relevant dose range in subjects with type 1 diabetes mellitus. Clinical Pharmacokinet. doi: 10.1007/s40262-016-0473-5 .

5. Heise T, Pieber TR, Danne T, Erichsen L, Haahr H. Faster onset and greater early exposure and glucose-lowering effect with faster-acting insulin aspart vs. insulin aspart: a pooled analysis in subjects with type 1 diabetes [abstract]. Diabetes. 2016;65(Suppl. 1):A239.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prandial Insulins: A Person-Centered Choice;Current Diabetes Reports;2024-04-03

2. Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System;Diabetes Technology & Therapeutics;2024-03-01

3. Results of biosimilar assessing of insulin aspart preparations of Russian and foreign production using the hyperinsulinemic euglycemic clamp method and studying the use of a new ultra-fast-acting Russian biosimilar in pumps;Meditsinskiy sovet = Medical Council;2024-02-26

4. The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus;Journal of Diabetes Science and Technology;2023-11-08

5. Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial;The Lancet Diabetes & Endocrinology;2023-11